AR039861A1 - Preparaciones farmaceuticas para la aplicacion oral que contienen resinas intercambiadoras de iones cargadas con el producto activo, asi como espesantes formadores de gel pseudoplasticos - Google Patents

Preparaciones farmaceuticas para la aplicacion oral que contienen resinas intercambiadoras de iones cargadas con el producto activo, asi como espesantes formadores de gel pseudoplasticos

Info

Publication number
AR039861A1
AR039861A1 ARP030101867A ARP030101867A AR039861A1 AR 039861 A1 AR039861 A1 AR 039861A1 AR P030101867 A ARP030101867 A AR P030101867A AR P030101867 A ARP030101867 A AR P030101867A AR 039861 A1 AR039861 A1 AR 039861A1
Authority
AR
Argentina
Prior art keywords
ion exchanger
active product
preparation according
pharmaceutical preparation
oral application
Prior art date
Application number
ARP030101867A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR039861A1 publication Critical patent/AR039861A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Preparaciones farmacéuticas para la aplicación oral, que contiene uno o varios productos activos, que están enlazados sobre un intecambiador de iones. Para mejorar la estabilidad física y la aceptancia, especialmente en el caso de los animales, está contenido un formador de gel, pseudoplástico, a modo de espesante. Reivindicación 2: Preparación farmacéutica según la reivindicación 1, caracterizada porque contiene a modo de formador de gel, intrínsicamente viscoso, ácido poliacrílico, xantano, celulosa microcristalina, éteres de celulosa, bentonita, dióxido de silicio altamente dispersado o una mezcla de los citados formadores de gel. Reivindicación 3: Preparación farmacéutica según la reivindicación 1, caracterizada porque el intercambiador de iones es un intercambiador de iones ácido. Reivindicación 5: Preparación farmacéutica según la reivindicación 1, caracterizada porque el producto activo, enlazado sobre el intercambiador de iones es un antibiótico de quinolona. Reivindicación 6: Preparación farmacéutica según la reivindicación 1, caracterizada porque el producto activo, enlazado sobre el intercambiador de iones es Pradofloxacin. Reivindicación 7: Preparación farmacéutica según la reivindicación 1, caracterizado porque el producto activo, enlazado sobre el intercambiador de iones de Enrofloxacin.
ARP030101867A 2002-05-31 2003-05-28 Preparaciones farmaceuticas para la aplicacion oral que contienen resinas intercambiadoras de iones cargadas con el producto activo, asi como espesantes formadores de gel pseudoplasticos AR039861A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker

Publications (1)

Publication Number Publication Date
AR039861A1 true AR039861A1 (es) 2005-03-02

Family

ID=29432468

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP030101867A AR039861A1 (es) 2002-05-31 2003-05-28 Preparaciones farmaceuticas para la aplicacion oral que contienen resinas intercambiadoras de iones cargadas con el producto activo, asi como espesantes formadores de gel pseudoplasticos
ARP160102580A AR105798A2 (es) 2002-05-31 2016-08-23 Preparaciones farmacéuticas para la aplicación oral, que contienen resinas intercambiadoras de iones cargadas con el producto activo, así como formadores de gel intrínsicamente viscosos a modo de espesantes

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP160102580A AR105798A2 (es) 2002-05-31 2016-08-23 Preparaciones farmacéuticas para la aplicación oral, que contienen resinas intercambiadoras de iones cargadas con el producto activo, así como formadores de gel intrínsicamente viscosos a modo de espesantes

Country Status (28)

Country Link
US (1) US8545829B2 (es)
EP (1) EP1513500B1 (es)
JP (2) JP5350574B2 (es)
KR (3) KR101258373B1 (es)
CN (1) CN1671361B (es)
AR (2) AR039861A1 (es)
AT (1) ATE421317T1 (es)
AU (1) AU2003242545B2 (es)
BR (2) BRPI0311511B1 (es)
CA (1) CA2487648C (es)
CR (1) CR7598A (es)
DE (2) DE10224086A1 (es)
DK (1) DK1513500T3 (es)
ES (1) ES2319115T3 (es)
HK (1) HK1083200A1 (es)
HR (1) HRP20041219B1 (es)
IL (2) IL165322A0 (es)
MX (1) MXPA04011820A (es)
MY (1) MY140953A (es)
NO (1) NO333939B1 (es)
PL (1) PL207269B1 (es)
PT (1) PT1513500E (es)
RU (1) RU2380091C2 (es)
SI (1) SI1513500T1 (es)
TW (1) TWI333422B (es)
UA (1) UA84270C2 (es)
WO (1) WO2003101422A2 (es)
ZA (1) ZA200409616B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
EP1830851A2 (en) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
CA2661576A1 (en) * 2006-09-26 2008-04-03 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
CN102046202A (zh) * 2008-03-26 2011-05-04 塔罗制药北美有限公司 用于口服药剂的稳定脂质组合物
NZ602120A (en) 2010-03-12 2015-02-27 Monsanto Technology Llc Agrochemical gel compositions
HUE029400T2 (en) * 2010-05-19 2017-03-28 Astellas Pharma Inc Pharmaceutical composition containing Solifenacin
CA2852447A1 (en) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
AU2019260015A1 (en) 2018-04-25 2020-12-17 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204713A (ja) 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
EP0610341B1 (en) * 1991-10-28 1996-09-18 The Procter & Gamble Company Beverage thickener/emulsifier system
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
PT882049E (pt) * 1996-02-23 2003-04-30 Bayer Ag Acidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo-¬4.3.0|nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-quinolino-carboxilicos eventualmente substituidos e seus derivados
US5980882A (en) 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
ATE411047T1 (de) 1999-07-14 2008-10-15 Schering Plough Ltd Maskieren des geschmacks der oralen flüssigen chinolon-zubereitungen mit ionenaustauscherharzen
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
WO2003101422A2 (de) 2003-12-11
IL165322A (en) 2015-11-30
DK1513500T3 (da) 2009-05-11
DE10224086A1 (de) 2003-12-11
IL165322A0 (en) 2006-01-15
CR7598A (es) 2008-07-31
TWI333422B (en) 2010-11-21
AU2003242545A1 (en) 2003-12-19
HRP20041219A2 (en) 2006-02-28
NO333939B1 (no) 2013-10-28
DE50311123D1 (de) 2009-03-12
BRPI0311511B1 (pt) 2018-07-10
CN1671361B (zh) 2010-05-12
US8545829B2 (en) 2013-10-01
KR20120006092A (ko) 2012-01-17
EP1513500A2 (de) 2005-03-16
UA84270C2 (ru) 2008-10-10
MXPA04011820A (es) 2005-03-31
EP1513500B1 (de) 2009-01-21
JP2006503806A (ja) 2006-02-02
AR105798A2 (es) 2017-11-08
PT1513500E (pt) 2009-04-02
SI1513500T1 (sl) 2009-06-30
PL207269B1 (pl) 2010-11-30
AU2003242545B2 (en) 2010-02-18
ATE421317T1 (de) 2009-02-15
KR20050010015A (ko) 2005-01-26
HK1083200A1 (en) 2006-06-30
JP2011012087A (ja) 2011-01-20
US20060177414A1 (en) 2006-08-10
BR0311511A (pt) 2005-02-22
ES2319115T3 (es) 2009-05-04
HRP20041219B1 (hr) 2013-05-31
BRPI0311511A (es) 2005-02-22
RU2004139022A (ru) 2005-07-10
ZA200409616B (en) 2006-05-31
RU2380091C2 (ru) 2010-01-27
JP5350574B2 (ja) 2013-11-27
TW200406230A (en) 2004-05-01
WO2003101422A3 (de) 2004-12-09
KR101258373B1 (ko) 2013-04-30
CA2487648C (en) 2012-03-13
BRPI0311511A8 (pt) 2017-07-11
NO20045700L (no) 2004-12-29
KR20120123607A (ko) 2012-11-08
MY140953A (en) 2010-02-12
PL373456A1 (en) 2005-08-22
CA2487648A1 (en) 2003-12-11
CN1671361A (zh) 2005-09-21

Similar Documents

Publication Publication Date Title
AR039861A1 (es) Preparaciones farmaceuticas para la aplicacion oral que contienen resinas intercambiadoras de iones cargadas con el producto activo, asi como espesantes formadores de gel pseudoplasticos
PE20110010A1 (es) Formulaciones liquidas de fenilefrina
MY145148A (en) Pharmaceutical formulation comprising an antibiotic, a triazole and a carticosteroid
RS52120B (en) STERILE IMMUNE RESPONSE MODIFIER FORMULATIONS AND PROCEDURES
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
HN2000000267A (es) Oxazolidinonas substituidas y su uso
ME00482B (me) Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje
TW200640908A (en) Chemical compounds
BRPI0820308B8 (pt) composição farmacêutica compreendendo oxi-hidróxido de ferro em alta carga, seus usos e seus processos de preparação, e comprimido
NO20075111L (no) Farmasoytisk sammensetning
EP1993567A4 (en) PER OS ADMINISTRABLE GALLIUM PREPARATIONS AND METHODS OF USE
MX354416B (es) Formulaciones a base de nalbufina y sus usos.
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
SE0302546D0 (sv) New compounds
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
BRPI0611526A2 (pt) composição tópica contendo gelatina
DE60311665D1 (de) Pharmazeutische zusammensetzungen
EA200702386A1 (ru) Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
WO2006105741A3 (en) Topical pharmaceutical formulation containing nimesulide
GR1004331B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος

Legal Events

Date Code Title Description
FC Refusal